ATI RN
Chapter 14 Drugs for the Reproductive System Questions
Question 1 of 5
When nonpharmacological treatment fails for constipation, which drug would be a first-line treatment for constipation during pregnancy?
Correct Answer: A
Rationale: The correct answer is A: Docusate sodium. It is a stool softener commonly used during pregnancy due to its safety profile. It helps to soften the stool, making it easier to pass without straining, which is important in preventing constipation. B: Magnesium citrate is not recommended during pregnancy due to its potential to cause diarrhea and electrolyte imbalance. C: Castor oil is not recommended during pregnancy as it can induce labor and has potential side effects. D: Mineral oil is not recommended during pregnancy due to its potential to interfere with nutrient absorption and cause aspiration pneumonia if accidentally inhaled.
Question 2 of 5
A client is to receive 10 mg nalbuphine by slow intravenous push for pain relief during labor. During which phase of uterine contractions will the nurse plan to administer nalbuphine?
Correct Answer: C
Rationale: The correct answer is C: Between uterine contractions. Administering nalbuphine during contractions can lead to decreased uterine blood flow, potentially compromising fetal oxygenation. Waiting until between contractions allows for optimal fetal oxygenation and minimizes the risk of uterine hyperstimulation. Administering at the end of a contraction or at any time during a contraction may still pose risks to the fetus.
Question 3 of 5
A client has an epidural for pain control during labor. During the assessment, the nurse notes a drop in the client's blood pressure. Which priority nursing intervention would the nurse do?
Correct Answer: B
Rationale: The correct answer is B: Turn her on her left side. Rationale: 1. Turning the client on her left side promotes blood flow to the placenta, increasing perfusion to the fetus. 2. This position helps alleviate hypotension by preventing compression of the vena cava. 3. It is a non-invasive and immediate intervention to address the drop in blood pressure. Summary: A: Administering low-flow oxygen is not the priority in this case as hypotension is likely due to epidural-induced vasodilation, not hypoxia. C: Assessing urinary output is important but not the immediate priority when addressing a drop in blood pressure. D: Monitoring vaginal bleeding is not relevant to the drop in blood pressure related to epidural administration.
Question 4 of 5
It is mandatory to have maternal signed consent before administering which newborn drug?
Correct Answer: C
Rationale: Step 1: Maternal consent is required for Hepatitis B vaccine series as it involves administering a vaccine to the newborn, which may have potential risks. Step 2: The Hepatitis B vaccine series is given as a preventive measure against Hepatitis B infection. Step 3: Maternal consent ensures that the mother is informed about the benefits and risks of the vaccine for her newborn. Step 4: Without maternal consent, healthcare providers cannot administer the Hepatitis B vaccine series to the newborn. Summary: Choice A (Erythromycin eye ointment) is typically administered routinely without requiring maternal consent. Choice B (Phytonadione) is a vitamin supplement given to newborns to prevent bleeding disorders, usually without the need for maternal consent. Choice D (Betamethasone injection) is a medication given to pregnant women to help fetal lung development and does not require maternal consent for administration to the newborn.
Question 5 of 5
The nurse is instructing a patient on the use of depot medroxyprogesterone acetate. Which statements are correct? (Select one that doesn't apply.)
Correct Answer: A
Rationale: Correct Answer: A Rationale: Depot medroxyprogesterone acetate is a progestin-only contraceptive that commonly causes changes in menstrual patterns. By inhibiting ovulation, it can lead to irregular bleeding, amenorrhea, or spotting. Patients should be informed about these potential changes. Increasing calcium intake is not specifically related to this medication. While patients can experience irregular bleeding initially, it is not accurate to say they do not have any changes in their periods. Depot medroxyprogesterone acetate is safe to use while breastfeeding, as it does not affect milk production or quality.